Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentrix Corporation (NASDAQ: CNXC) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 public company, Concentrix uses SEC reports to communicate details about its financial performance, risk factors, capital structure, and significant corporate events.
Among the key filings, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand revenue trends, operating income, non-GAAP measures referenced in earnings releases, cash flow, and segment information. Current reports on Form 8-K, such as those furnished for quarterly earnings announcements, give timely updates on results of operations and financial condition, and may include press releases as exhibits.
For those tracking ownership and governance, Forms 3, 4, and 5 (if available) can be used to monitor insider transactions by directors, officers, and significant shareholders. Proxy statements on Schedule 14A, when filed, typically provide information on executive compensation, board structure, and matters submitted to shareholder votes.
On Stock Titan, Concentrix filings are supplemented with AI-powered summaries that explain the main points of lengthy documents in clear language. Real-time updates from the EDGAR system help users see new CNXC filings as they appear, while AI-generated highlights make it easier to identify sections related to non-GAAP metrics, AI and technology investments, and other topics emphasized in the company’s earnings materials. This page is a useful starting point for anyone researching Concentrix’s regulatory history, financial reporting practices, and material disclosures.
Concentrix Corporation filed a current report to let investors know it has released its financial results for the quarter and year ended November 30, 2025. The company reported these results through a press release dated January 13, 2026, which is included in the filing as Exhibit 99.1.
The company notes that this information is being furnished under the SEC’s Item 2.02 for results of operations and financial condition, meaning it is provided for disclosure purposes and is not treated as formally filed for liability purposes under certain securities laws.
Concentrix Corporation (CNXC) reported an insider purchase by a reporting person who serves as President and CEO and Director. On 10/31/2025, the insider bought 1,000 shares of Common Stock at a price of $40 per share (Transaction Code: P), held as Direct (D) ownership. Following the transaction, the insider beneficially owns 287,661 shares.
Concentrix (CNXC) insider filing reports two transactions by the company’s President and CEO, who also serves as a Director. On 10/29/2025, the reporting person made a bona fide gift of 20,684 shares of common stock at $0, described as a transfer to a family trust in which the reporting person has no beneficial or pecuniary interest. Following this gift, the filing shows 284,661 shares held directly.
On 10/30/2025, the reporting person purchased 2,000 common shares at an average price of $42.0279, bringing direct beneficial ownership to 286,661 shares. Both holdings are reported as Direct (D) ownership.
Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.
Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.
Concentrix (CNXC) reported an insider transaction by an executive officer. On 10/27/2025, a Form 4 shows a code F disposition of 1,403 shares of common stock at $46.04. After this transaction, the reporting person directly beneficially owns 41,008 shares. The filer is listed as EVP, Global Sales, Acct Mgmt, and the filing was made by one reporting person.
Concentrix (CNXC) reported an insider share purchase by its President & CEO, who is also a Director. On 10/10/2025, the executive bought 1,000 shares of common stock at $45.35 per share (transaction code P). Following the transaction, the executive beneficially owns 305,345 shares, held directly.
Christopher A. Caldwell, President and CEO and Director of Concentrix Corp (CNXC), reported a sale of common stock on 10/07/2025. The filing shows 390 shares were sold at $47.76, leaving Mr. Caldwell with 304,345 shares held directly after the transaction. The Form 4 was signed by an attorney-in-fact on 10/09/2025. No options or derivative transactions were reported.
Jane Fogarty, Executive Vice President, Legal at Concentrix Corp (CNXC), reported a sale of company stock on 10/05/2025. The Form 4 shows 126 shares sold at a price of $48.26 per share, leaving 19,131 shares beneficially owned directly after the transaction. The filing is signed by an attorney-in-fact on 10/07/2025.
Concentrix Corporation presents interim unaudited consolidated financial statements prepared in accordance with SEC rules and GAAP with normal recurring adjustments. The filing discloses 69,120 and 68,849 shares issued as of August 31, 2025 and November 30, 2024, and 62,209 and 64,238 shares outstanding on those dates. The Company reports accounts receivable activity under factoring programs, with $127,000 outstanding at August 31, 2025 and sales of $328,000 during the three months ended August 31, 2024. In connection with the Webhelp acquisition, Concentrix recorded cross-currency interest rate swaps on $500,000 of senior notes to synthetically convert $250,000 of 2026 notes and $250,000 of 2028 notes into euro-based debt at weighted rates of 5.12% and 5.18%, respectively. Term loan principal outstanding decreased to $1,350,000 at August 31, 2025 from $1,500,000 on November 30, 2024, after voluntary prepayments of $150,000 in the nine months. The company amended its credit facilities (Restated Credit Agreement) providing multiple term and delayed-draw facilities and a $1.1 billion revolving credit capacity. The Securitization Facility commitment was increased to $700,000. Concentrix repurchased 2,247 shares for $112,774 in the nine months ended August 31, 2025 and reports approximately $495,402 remaining under its repurchase authorization. Pension plans were underfunded by $81,974 at August 31, 2025. The Company states it was in compliance with covenant requirements as of August 31, 2025.
Concentrix Corp director and President/CEO Christopher A. Caldwell reported three transactions on 09/30/2025. He acquired 1,000 shares of Common Stock at $47.435, exercised 9,363 employee stock options with an exercise price of $44.52, and had 8,990 shares withheld to satisfy the option exercise price and taxes. After these transactions the reported beneficial ownership totals shown on the form include 313,725 and similar post-transaction balances for direct holdings.